You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《美股業績》藥房連鎖Walgreens(WBA.US)季度同售銷售遜預期 股價跌6%
道指成份股,美國藥房連鎖Walgreens(WBA.US)公布截至去年11月底止首財季業績。受累季內就鴉片成分藥成癮問題和解錄65億美元稅前開支,季度股東應佔虧損37.21億美元,對上年度同期純利35.8億美元。每股季度攤薄虧損4.31美元,經調整後為每股純利1.16美元。季度銷售333.82億美元,按年跌1.5%。 在流感高峰導致止咳及感冒藥需求高企下,公司季度藥房銷售按年跌4%,同店銷售按年升4.8%,差於市場預期的5%。Walgreens股價昨日(5日)跌6.1%報35.19美元。 公司財務總監James Kehoe在業績電話會議上表示,短期不考慮任何模式併購活動,稱需集中整合業務,又稱公司或會進行目標性收購,但僅限數億美元規模。公司2021年以55億美元收購醫護服務商VillageMD及CareCentrix的大部分股權,VillageMD其後動用90億美元併購緊急護理供應商Summit Health。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account